Outcomes in early-stage cervical cancer patients with high-risk features on conization followed by low-risk features on radical hysterectomy
Smith, B, Backes, F.J, O'Malley, D.M, Cohn, D.E, Fowler, J.M, Copeland, L.J, Salani, R
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Change in genetics service model increases ovarian cancer patient referrals and decreases time to consultation: Improving compliance with guideline-based quality care
Senter, L, O'Malley, D.M, Backes, F.J, Copeland, L.J, Fowler, J.M, Salani, R, Cohn, D.E
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Rucaparib in patients with relapsed, primary platinum-sensitive high-grade ovarian carcinoma with germline or somatic BRCA mutations: Integrated summary of efficacy and safety from the phase II study ARIEL2
Konecny, G.E, Oza, A.M, Tinker, A.V, Coleman, R.L, O'Malley, D.M, Maloney, L, Wride, K, Rolfe, L, McNeish, I, Swisher, E.M
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated comprehensive cancer center
ElNaggar, A.C, Liang, M.I, O'Malley, D.M, Hade, E.M, Copeland, L.J, Fowler, J.M, Salani, R, Backes, F.J, Cohn, D.E
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
BRCA1 and RAD51C promoter hypermethylation confer sensitivity to the PARP inhibitor rucaparib in patients with relapsed, platinum-sensitive ovarian carcinoma in ARIEL2 Part 1
Swisher, E.M, Harrell, M.I, Lin, K, Coleman, R.L, Konecny, G.E, Tinker, A.V, O'Malley, D.M, McNeish, I, Kaufmann, S.H
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal cytoreductive surgery
Bixel, K, Vetter, M.H, Cohn, D.E, Fowler, J.M, Copeland, L.J, O'Malley, D.M, Salani, R, Backes, F.J
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Nomogram predicting individual survival following recurrence in advanced stage high-grade ovarian cancer from NRG Oncology/Gynecologic Oncology Group randomized trials of platinum and paclitaxel
Rose, P.G, Java, J, O'Malley, D.M, Geller, M.A, Muggia, F.M, Armstrong, D.K, Bookman, M.A, Brady, M.F, Copeland, L.J
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
A single institution pilot study for universal Lynch syndrome screening: A key step towards statewide screening and care
Cosgrove, C.M, Backes, F.J, Hampel, H, Salani, R, Copeland, L.J, O'Malley, D.M, Fowler, J.M, Pearlman, R, Cohn, D.E, Goodfellow, P.J
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
GOG 186H: A randomized phase II evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin) in the treatment of recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer
Cohn, D.E, Sill, M, Walker, J.L, O'Malley, D.M, Nagel, C.I, Rutledge, T, Bradley, W.H, Richardson, D.L, Moxley, K, Aghajanian, C
Published in Gynecologic oncology (01.06.2016)
Published in Gynecologic oncology (01.06.2016)
Get full text
Journal Article
Adherence to a standard algorithm results in high negative predictive value of sentinel lymph node assessment using indocyanine green (ICG) and isosulfan blue (ISB) dyes in endometrial cancer
O'Malley, D.M, Salani, R, Cohn, D.E, Copeland, L.J, Fowler, J.M
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Neoadjuvant chemotherapy for advanced ovarian, fallopian tube and peritoneal cancer: An ancillary study of GOG 262
Chan, J.K, Brady, M.F, Penson, R.T, Monk, B.J, Kapp, D.S, Birrer, M.J, Huang, H, Walker, J.L, DiSilvestro, P.A, Rubin, S.C, Martin, L.P, Davidson, S.A, Huh, W.K, O'Malley, D.M, Boente, M.P, Michael, H
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): A Gynecologic Oncology Group study
Miller, A, O'Malley, D.M, Mannel, R.S, Behbakht, K, Bakkum-Gamez, J.N, Michael, H
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article
Setting the bar: Compliance with ovarian cancer quality indicators at a National Cancer Institute (NCI)-designated Comprehensive Cancer Center (CCC)
ElNaggar, A.C, Nekkanti, S, O'Malley, D.M, Hade, E.M, Copeland, L.J, Fowler, J.M, Salani, R, Backes, F.J, Cohn, D.E
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Clinicopathologic features associated with defective DNA mismatch repair (MMR): A GOG 0210 cohort study of 1041 endometrioid endometrial cancer cases
Powell, M.A, Schmidt, A, Broaddus, R, Ramirez, N, Tritchler, D, Ali, S, Lankes, H, O'Malley, D.M, Goodfellow, P.J
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab, and veliparib (ABT-888) in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: A Gynecologic Oncology Group study
Brady, W.E, Armstrong, D.K, Moore, K.N, DiSilvestro, P.A, O'Malley, D.M, Tenney, M.E, Rose, P.G, Fracasso, P.M
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
A phase III randomized controlled clinical trial of carboplatin and paclitaxel alone or in combination with bevacizumab followed by bevacizumab and secondary cytoreductive surgery in platinum-sensitive, recurrent ovarian, peritoneal primary and fallopian tube cancer (Gynecologic Oncology Group 0213)
Brady, M.F, Herzog, T.J, Sabbatini, P, Armstrong, D.K, Walker, J.L, Kim, B.G, Fujiwara, K, Tewari, K.S, O'Malley, D.M
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Outpatient rapid desensitization for gynecologic oncology patients with moderate to severe hypersensitivity reactions to platinums
Li, Q, Cohn, D.E, Rhoades, A.G, Backes, F.J, Copeland, L.J, Fowler, J.M, Salani, R, O'Malley, D.M
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article